ENANTA PHARMACEUTICALS INC (ENTA) Stock Cash Flow
NASDAQ:ENTA - Nasdaq - US29251M1062 - Common Stock - Currency: USD
| TTM (2024-12-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -104.93M | -116.05M | -133.82M | -121.76M | -79.00M | |||
| Depreciation Amortization | 2.58M | 2.34M | 2.37M | 2.97M | 3.33M | |||
| Income Taxes - Deferred | N/A | N/A | 0.00 | 0.00 | 350.00K | |||
| Change In Working Capital | 8.63M | 7.13M | 8.02M | 6.79M | -13.69M | |||
| Interest Paid | N/A | 11.71M | N/A | N/A | N/A | |||
| Taxes Paid | N/A | 241.00K | 4.90M | 0.00 | 30.00K | |||
| Other non cash items | 23.14M | 27.82M | 20.27M | 27.21M | 19.01M | |||
| OPERATING CASH FLOW | -70.58M | -78.76M | -103.15M | -84.78M | -70.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -25.91M | -17.95M | -9.06M | -2.13M | -750.00K | |||
| Other Investing Activity | 166.16M | 76.18M | -44.52M | 57.02M | 37.74M | |||
| INVESTING CASH FLOW | 140.25M | 58.23M | -53.58M | 54.90M | 36.99M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 241.00K | 147.00K | 2.21M | 21.26M | 3.61M | |||
| Other Financing Activity | -25.50M | -27.77M | 195.92M | -1.23M | -530.00K | |||
| FINANCING CASH FLOW | -25.26M | -27.63M | 198.13M | 20.03M | 3.08M | |||
| CHANGE IN CASH | 44.42M | -48.16M | 41.40M | -9.85M | -29.93M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -70.58M | -78.76M | -103.15M | -84.78M | -70.00M | |||
| Capital Expenditure | -25.91M | -17.95M | -9.06M | -2.13M | -750.00K | |||
| FREE CASH FLOW | -96.48M | -96.71M | -112.21M | -86.91M | -70.75M | |||
All data in USD